Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of the COVID-19 Pandemic on the Management and End-of-life Care of Unresectable Pancreatic Cancer.
Kasuga A, Nojima M, Okamoto T, Ishitsuka T, Yamada M, Nakagawa H, Udagawa S, Mori C, Mie T, Furukawa T, Yamada Y, Takeda T, Matsuyama M, Sasaki T, Ozaka M, Sasahira N. Kasuga A, et al. Among authors: udagawa s. Intern Med. 2022 Dec 15;61(24):3641-3649. doi: 10.2169/internalmedicine.0492-22. Epub 2022 Oct 5. Intern Med. 2022. PMID: 36198597 Free PMC article.
Post-Systemic Chemotherapy Prognoses of Recurrent/Metastatic Soft Tissue Sarcoma Patients with Retroperitoneal/Intra-Abdominal Origin versus Those with Extremities/Trunk Origin.
Nakano K, Fukuda N, Sato Y, Urasaki T, Ohmoto A, Wang X, Hayashi N, Suto H, Udagawa S, Oki R, Yunokawa M, Ono M, Tomomatsu J, Minami Y, Hayakawa K, Tanizawa T, Ae K, Matsumoto S, Takahashi S. Nakano K, et al. Among authors: udagawa s. Oncology. 2022;100(4):238-246. doi: 10.1159/000522303. Epub 2022 Jan 31. Oncology. 2022. PMID: 35100601
Clinical characteristics of sarcoma cases in which long-term disease control was achieved with trabectedin treatment: A retrospective study.
Ohmoto A, Nakano K, Fukuda N, Wang X, Urasaki T, Hayashi N, Suto H, Udagawa S, Oki R, Sato Y, Yunokawa M, Ono M, Saito M, Minami Y, Hayakawa K, Tanizawa T, Ae K, Matsumoto S, Tomomatsu J, Takahashi S. Ohmoto A, et al. Among authors: udagawa s. PLoS One. 2023 Mar 1;18(3):e0280508. doi: 10.1371/journal.pone.0280508. eCollection 2023. PLoS One. 2023. PMID: 36857355 Free PMC article.
Lymph-node ratio as a risk factor for recurrence following neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy for locally advanced esophageal squamous cell carcinoma.
Tamba M, Okamura A, Osumi H, Imamura Y, Kanamori J, Ogura M, Fukuoka S, Yoshino K, Udagawa S, Wakatsuki T, Shinozaki E, Watanabe M, Yamaguchi K, Chin K, Ooki A. Tamba M, et al. Among authors: udagawa s. Esophagus. 2025 Jan 4. doi: 10.1007/s10388-024-01103-6. Online ahead of print. Esophagus. 2025. PMID: 39755858
Chilblain lupus-like cutaneous reaction associated with systemic lupus erythematosus induced by immune checkpoint inhibitor.
Takeda K, Nakano K, Udagawa S, Fukuda N, Nishizawa A, Ono M, Urasaki T, Tomomatsu J, Mochizuki T, Shiga T, Kogawa T, Takahashi S, Kitano S. Takeda K, et al. Among authors: udagawa s. Rheumatology (Oxford). 2021 Dec 24;61(1):e13-e14. doi: 10.1093/rheumatology/keab670. Rheumatology (Oxford). 2021. PMID: 34463707 No abstract available.
125 results